New pill may beat old drug for stubborn eczema

NCT ID NCT05969730

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether baricitinib (a newer pill) works better than azathioprine (an older pill) for adults with moderate-to-severe eczema. Both groups also used steroid creams. The goal was to see which combination reduces skin redness, thickness, and itching more effectively after 12 weeks. 40 adults took part, and the results help doctors choose the best treatment for controlling this chronic skin condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Iran

    Sari, Mazandaran, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.